Clinical efficacy and safety of aprepitant triple therapy for the prevention of highly and moderately emetogenic multiple-day chemotherapy-induced nausea and vomiting

ZHA Quanbin; TIAN Shenwang; GUO Yuhua; SHI Yongkang

doi:10.3969/j.issn.1674-4136.2018.02.010

Home>Articles>Clinical efficacy and safety of aprepitant triple therapy for the prevention of highly and moderately emetogenic multiple-day chemotherapy-induced nausea and vomiting

DOI: 10.3969/j.issn.1674-4136.2018.02.010

Clinical efficacy and safety of aprepitant triple therapy for the prevention of highly and moderately emetogenic multiple-day chemotherapy-induced nausea and vomiting

ZHA Quanbin

TIAN Shenwang

GUO Yuhua

SHI Yongkang

Machine-generated Keywords：

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 109-111 )

Chinese Journal of Surgical Oncology

ISTIC

ISSN：1674-4136

Year, Vol.(Issue)：2018,10(2)